The grant is intended to develop and produce an oral liquid version of SER-155. Credit: YURIMA/Shutterstock.com. Seres ...
The DREAMM-7 trial showed tolerability and safety profiles consistent with those observed for individual therapies. Credit: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback